Related references
Note: Only part of the references are listed.Glycemic Response and Attainment of A1C Goals Following Newly Initiated Insulin Therapy for Type 2 Diabetes
Gregory A. Nichols et al.
DIABETES CARE (2012)
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi et al.
DIABETES CARE (2012)
Optimization of insulin therapy in patients with Type 2 diabetes mellitus: beyond basal insulin
B. T. Blak et al.
DIABETIC MEDICINE (2012)
Post-marketing studies of new insulins: sales or science?
Edwin A. M. Gale
BMJ-BRITISH MEDICAL JOURNAL (2012)
Clinical Outcomes After Insulin Initiation in Patients with Type 2 Diabetes: 24-Month Results from INSTIGATE
Andreas Liebl et al.
Diabetes Therapy (2012)
Increase in direct diabetes-related costs and resource use in the 6 months following initiation of insulin in patients with type 2 diabetes in five European countries: data from the INSTIGATE study
Stephen Jones et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2012)
Clinical outcomes after insulin initiation in patients with type 2 diabetes: 6-month data from the INSTIGATE observational study in five European countries
Andreas Liebl et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Dipeptidyl peptidase-4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials
K. Esposito et al.
DIABETES OBESITY & METABOLISM (2011)
Multiple HbA1c targets and insulin analogues in type 2 diabetes: a systematic review
Dario Giugliano et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2011)
Prandial-basal insulin regimens plus oral antihyperglycaemic agents to improve mealtime glycaemia: initiate and progressively advance insulin therapy in type 2 diabetes
S. M. Jain et al.
DIABETES OBESITY & METABOLISM (2010)
Baseline characteristics of the Indian cohort from the IMPROVE™ study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes
Siddharth Shah et al.
ADVANCES IN THERAPY (2009)
Once-daily insulin detemir in a cohort of insulin-naive patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study
L. F. Meneghini et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study
Stephen Jones et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Consequences of Delaying Progression to Optimal Therapy in Patients with Type 2 Diabetes Not Achieving Glycemic Goals
William C. Hsu
SOUTHERN MEDICAL JOURNAL (2009)
Diabetes and metabolism - Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease
Benjamin A. Steinberg et al.
AMERICAN HEART JOURNAL (2008)
Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK
A. Rubino et al.
DIABETIC MEDICINE (2007)
Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Antihyperglycaemic treatment of type 2 diabetes:: results from a national diabetes register
B. Ellasson et al.
DIABETES & METABOLISM (2007)
Delay of insulin addition to oral combination therapy despite inadequate glycemic control
Gregory A. Nichols et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2007)
Achieving glycemic goals in type 2 diabetes
Zachary T. Bloomgarden
DIABETES CARE (2007)
Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes - The Diabetes Outcomes in Veterans Study (DOVES)
GH Murata et al.
DIABETES CARE (2003)
Revealing the cost of Type II diabetes in Europe
B Jönsson
DIABETOLOGIA (2002)
Share Paper
